Ripamonti, D., Comi, L., Francavilla, A., Valenti, D., Cossu, M., Moschese, D., et al. (2024). Long-term durability of dolutegravir + darunavir/cobicistat dual regimen in highly antiretroviral-experienced people living with HIV (DoDaco study). In Abstracts from the 16° Italian Conference on AIDS and Antiviral Research (pp.163-164) [10.1136/sextrans-ICAR-2024.142].

Long-term durability of dolutegravir + darunavir/cobicistat dual regimen in highly antiretroviral-experienced people living with HIV (DoDaco study)

Lapadula, G;Mezzadri, L;Bonfanti, P;
2024

abstract + poster
HIV
English
16° Italian Conference on AIDS and Antiviral Research - Dal 19 al 21 giugno 2024
2024
Abstracts from the 16° Italian Conference on AIDS and Antiviral Research
2024
100
S1
163
164
P16
https://sti.bmj.com/content/100/Suppl_1/A163
open
Ripamonti, D., Comi, L., Francavilla, A., Valenti, D., Cossu, M., Moschese, D., et al. (2024). Long-term durability of dolutegravir + darunavir/cobicistat dual regimen in highly antiretroviral-experienced people living with HIV (DoDaco study). In Abstracts from the 16° Italian Conference on AIDS and Antiviral Research (pp.163-164) [10.1136/sextrans-ICAR-2024.142].
File in questo prodotto:
File Dimensione Formato  
Ripamonti-2024-16° Italian Conference on AIDS and Antiviral Research-AbstractPoster-VoR.pdf

accesso aperto

Descrizione: No commercial re-use. See rights and permissions. Published by BMJ.
Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Altro
Dimensione 528 kB
Formato Adobe PDF
528 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/494799
Citazioni
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
Social impact